سعر ايزوريفا 150/300 مجم 10 كبسولات 2022

Isorifa capsules containing isoniazid 150 mg and rifampicin 300 mg, pack of 10, for tuberculosis.

• Treatment of all forms of tuberculosis, including fresh, advanced and chronic cases (another antituberculosis drug may be given concurrently until susceptibility is confirmed).Population: Adultselectronic medicines compendium (eMC) / MHRA

• Rifampicin: thrombocytopenia (often with intermittent therapy), leukopenia, influenza-like symptoms, gastrointestinal upset, orange-red discolouration of body fluids, hepatotoxicity. Isoniazid: peripheral neuropathy, hepatitis, hypersensitivity.International label, equivalent formulation · electronic medicines compendium (eMC) / MHRA

• Hypersensitivity to rifamycins, isoniazid or any excipient; jaundice; concurrent saquinavir/ritonavir; concomitant use of medicines strongly affected by CYP/transporter induction (e.g. lurasidone, sofosbuvir, daclatasvir, telaprevir, cabotegravir).International label, equivalent formulation · electronic medicines compendium (eMC) / MHRA

• Both components can cause liver dysfunction; obtain baseline LFTs, bilirubin, creatinine, CBC and platelets; see patients at least monthly. Discontinue if serious hepatic injury develops.International label, equivalent formulation · electronic medicines compendium (eMC) / MHRA

• CYP3A4 / transporter substrates (many antiretrovirals, oral contraceptives, anticoagulants, etc.)Rifampicin is a potent inducer and may substantially reduce plasma concentrations of co-administered drugs; review concurrent therapy carefully.electronic medicines compendium (eMC) / MHRA

English text not available for this section.